Prostate cancer researchers and clinicians recommend reconsidering screening guidelines, saying benefits may outweigh potential harms.
An estimated 174,650 new cases of prostate cancer will be diagnosed in 2019. In its early stages, prostate cancer may have few or no symptoms.
More than one-fourth of survey respondents strongly objected to losing access to the cancer screening late in life, surprising researchers.
“While it wasn’t completely surprising, the fact that the proportion of men seeking definitive treatment declined the most suggested that more men are choosing to delay treatment after diagnosis,” says study author